1887

Abstract

Summary

We examined the properties of the mouse serum lipoprotein responsible for specific neutralization of the endogenous mouse xenotropic (X-tropic) type C retrovirus. The anti-X-tropic virus activity of the mouse lipoprotein neutralizing factor (NF) could not be blocked by sugars or lectins. Moreover, neutralization did not involve rupture of the virion core. Sucrose density gradient analysis of X-tropic virus mixed with various lipoprotein preparations demonstrated that the binding of complete virions to NF is associated with the neutralization.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-10-2657
1988-10-01
2024-05-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/10/JV0690102657.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-10-2657&mimeType=html&fmt=ahah

References

  1. ARNSTEIN P., LEVY J. A., OSHIRO L. S., PRICE P. J., SUK W., LENNETTE E. H. 1974; Recovery of murine xenotropic type-C virus from C57L mice. Journal of the National Cancer Institute 53:1787–1792
    [Google Scholar]
  2. FISCHINBER P. J., IHLE J. N., BOLOGNESI D. P., SCHAFER W. 1976; Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology 71:364–371
    [Google Scholar]
  3. HOFFMAN A. D., BANAPOUR B., LEVY J. A. 1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:325–335
    [Google Scholar]
  4. KANE J. P., SATA T., HAMILTON R. L., HAVEL R. J. 1975; Apoprotein composition of very low density lipoproteins of human serum. Journal of Clinical Investigation 56:1622–1634
    [Google Scholar]
  5. KANE J. P., HARDMAN D. A., DIMPFL J. C., LEVY J. A. 1979; Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum. Proceedings of the National Academy of Sciences, U.S.A 76:5957–5961
    [Google Scholar]
  6. LEONG J. C, KANE J. P., OLESZKO O., LEVY J. A. 1977; Antigen-specific non-immunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proceedings of the National Academy of Sciences, U.S.A 74:276–280
    [Google Scholar]
  7. LEVY J. A. 1973; Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and otlwr mouse strains. Science 182:1151–1153
    [Google Scholar]
  8. LEVY J. A. 1974; Autoimmunity and neoplasia. The possible role of C-type viruses. American Journal of Clinical Pathology 62:258–280
    [Google Scholar]
  9. LEVY J. A., IHLE I. N., OLESZKO O., BARNES R. D. 1975; Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera. Proceedings of the National Academy of Sciences, U.S.A. 11:5071–5075
    [Google Scholar]
  10. LEVY J. A., DIMPFL J., HARDMAN D., KANE J. P. 1982; Transfer of mouse anti-xenotropic virus neutralizing factor to human lipoproteins. Journal of Virology 42:365–371
    [Google Scholar]
  11. MONTELARO R. C, FISCHINGER P. J., LARRICK S. B., DUNLOP N. M., IHLE J N., FRANK H., SCHÄFER W., BOLOGNESI D. P. 1979; Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology 98:20–34
    [Google Scholar]
  12. PEEBLES P. T. 1975; An in vitro focus-induction assay for xenotropic murine leukemia virus, feline leukemia virus C and the feline-primate viruses RD-114/CCC/m-7. Virology 67:288–291
    [Google Scholar]
  13. SHARON N., LIS H. 1972; Lectins: cell-agglutinating and sugar-specific proteins. Science 177:949–959
    [Google Scholar]
  14. STEWART C. P., HENDRY E. B. 1935; The phospholipids of blood. Biochemical Journal 29:1683–1689
    [Google Scholar]
  15. VARNIER O. E., HOFFMAN A. D., NEXO B. A., LEVY J. A. 1984; Murine xenotropic type C viruses. V. Biologic and structural differences among three cloned xenotropic retroviruses isolated from kidney cells from one NZB mouse. Virology 132:79–84
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-10-2657
Loading
/content/journal/jgv/10.1099/0022-1317-69-10-2657
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error